New Zealand markets close in 4 hours 32 minutes

Baxter International Inc. (BAX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
85.96-0.32 (-0.37%)
At close: 04:00PM EST
85.56 -0.40 (-0.47%)
After hours: 06:06PM EST

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000

IndustryMedical Instruments & Supplies
Full-time employees50,000

Key executives

NameTitlePayExercisedYear born
Mr. Jose E. AlmeidaChairman, Pres & CEO1.37MN/A1962
Mr. James K. SaccaroExec. VP & CFO1.08MN/A1973
Mr. Giuseppe AccogliExec. VP & COO1.09M2.46M1971
Mr. Sean B. W. MartinSr. VP & Gen. Counsel943.45k1.31M1963
Mr. Cristiano FranziSr. VP & Pres for EMEA1.33M1.18M1963
Mr. Talvis P. LoveSr. VP & Chief Information OfficerN/AN/A1968
Ms. Stacey EisenSr. VP of Global CommunicationsN/AN/AN/A
Ms. Jeanne K. MasonSr. VP of HRN/AN/A1956
Mr. Andrew FryeSr. VP & Pres of APACN/AN/A1965
Mr. Wilber C. Boren IVPres of Advanced SurgeryN/AN/A1973
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Corporate governance

Baxter International Inc.’s ISS governance QualityScore as of 26 September 2021 is 9. The pillar scores are Audit: 10; Board: 6; Shareholder rights: 6; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.